Calidi Biotherapeutics Balance Sheet (2021-2026)

Reported Financials

Calidi Biotherapeutics Quarterly Balance Sheet

Periods 21 quarters

Latest Jun 2026

Calidi Biotherapeutics reported total assets of $0.01B and total liabilities of $0.00B for the quarter ended Jun 2026, down 23.0% year over year. This balance sheet covers 21 quarters of results from Jun 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	1.20M	1.06M	0.60M	0.33M	0.04M	0.37M	0.08M	0.67M	10.15M	1.95M	1.14M	0.84M	1.90M	9.59M	10.56M	5.28M	10.40M	5.60M	6.63M	4.10M
Cash & Current Investments	1.20M	1.06M	0.60M	0.33M	0.04M	0.37M	0.08M	0.67M	10.15M	1.95M	1.14M	0.84M	1.90M	9.59M	10.56M	5.28M	10.40M	5.60M	6.63M	4.10M
Receivables - NetNet Receivables						870.00		870.00
Receivables - OtherOther Receivables						870.00	870.00			2.90M		0.20M		0.20M	50,000.00M	0.05M		50,000.00M
Receivables						0.00M		870.00
Prepaid Assets	0.81M	0.42M	0.43M	0.43M	0.44M	0.41M	0.19M	0.12M	1.54M	2.35M	0.79M	0.79M	0.32M	0.64M	0.93M	0.77M	0.65M	0.66M	0.72M	1.36M
Current Assets	2.00M	1.48M	1.03M	0.76M	0.48M	0.79M	0.27M	0.80M	11.69M	4.30M	1.94M	1.63M	2.22M	10.23M	11.49M	6.05M	11.03M	6.26M	7.35M	5.43M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)					0.12M		0.23M	0.21M	0.19M					0.87M	0.80M	0.93M	0.85M	0.78M	0.76M	0.78M
Long-Term Investments	230.00M	230.00M	230.02M	230.18M	41.68M	42.45M	42.91M	43.21M
Long-Term Deferred Tax																		1.68M	1.34M
Other Non-Current Assets		0.28M	0.18M	0.08M		0.73M			1.64M	0.37M	0.71M	0.43M	0.42M	0.15M	0.34M	0.14M	0.34M	0.14M	0.34M	0.21M
Non-Current Assets	230.00M	230.29M	230.20M	230.26M	41.68M	42.45M	42.91M	43.21M	6.90M	5.72M	5.47M	4.81M	4.44M	3.96M	3.58M	3.30M	3.00M	2.60M	2.24M	1.78M
Assets	232.01M	231.77M	231.24M	231.02M	42.16M	2.60M	43.18M	44.01M	18.59M	10.02M	7.41M	6.43M	6.66M	14.18M	15.06M	9.35M	14.03M	8.86M	9.59M	7.20M
Liabilities
Current Liabilities
Accounts Payables		0.06M	0.04M	0.03M	0.10M	0.05M	0.14M	0.49M	5.10M	6.10M	6.50M	6.60M	6.80M	2.07M	1.21M	1.23M	1.15M	0.61M	0.90M	0.93M
Notes Payables					0.46M	1.22M	1.46M	1.49M			1.02M		0.60M	0.60M	0.60M	0.60M	0.60M	0.60M	0.60M	0.60M
Payables		0.06M	0.04M	0.03M	0.56M	1.28M	1.61M	1.98M	5.10M	6.10M	7.52M	6.60M	7.40M	2.67M	1.81M	1.83M	1.75M	1.21M	1.50M	1.53M
Accumulated Expenses	0.04M	0.35M	0.35M	0.35M	0.78M	3.23M	4.88M	5.93M	0.02M	5.43M	4.57M	3.24M	3.06M	2.34M	1.77M	1.93M	2.17M	1.81M	1.43M	1.13M
Other Accumulated Expenses						0.64M				0.05M	0.57M	0.60M	0.62M	0.64M	0.01M	0.01M	0.02M	0.01M	0.01M	0.01M
Short term Debt						1.00M			1.00M		0.21M	0.21M	0.22M	0.22M
Current Leases					0.05M	0.07M	0.07M	0.07M	0.06M	0.08M	0.07M	0.07M	0.07M	0.07M	0.07M	0.11M	0.11M	0.11M	0.15M	0.17M
Total Current Liabilities	0.05M	0.41M	0.39M	0.37M	1.34M	42.99M	6.62M	8.18M	10.87M	10.23M	14.95M	13.05M	11.58M	9.50M	5.43M	5.35M	5.19M	3.94M	3.84M	3.24M
Non-Current Liabilities
Capital Leases					0.07M	0.14M	0.13M	0.11M	0.10M	0.22M	0.20M	0.18M	0.17M	0.15M	0.13M	0.23M	0.20M	0.17M	0.15M	0.16M
Non-Current Debt						1.50M			1.95M	2.06M	3.30M	3.30M	3.30M	2.00M	1.10M	500.00M	0.40M	0.20M
Convertible Debt						0.80M			0.02M		3.38M	1.93M	1.77M
Non-Current Deferred Revenue	8.05M	8.05M
Preferred Stock Liabilities	230.00M	230.00M	230.02M	230.18M	41.68M	42.45M	42.91M	43.21M
Minority Interest													0.49M	0.43M	0.36M	0.31M	0.28M
Operating Leases					0.15M	0.31M	3.80M	3.55M	3.23M	3.04M	2.76M	2.46M	2.16M	1.85M	1.52M	0.99M	0.64M	0.28M	0.01M	0.01M
Other Non-Current Liabilities	20.89M	7.47M	13.42M	9.40M	8.94M	0.75M	0.66M	1.94M	3.46M	0.62M	0.65M	0.52M	0.16M	0.12M	0.08M	0.10M	0.19M	0.11M	0.06M	0.06M
Total Non-Current Liabilities	230.09M	16.04M	14.07M	9.71M	9.03M	1.07M	1.54M	4.58M	16.22M	17.63M	21.33M	17.66M	16.29M	12.10M	7.68M	7.18M	6.65M	4.99M	4.59M	4.01M
Total Liabilities	250.98M	263.38M	268.86M	270.66M	86.08M	53.04M	98.27M	107.72M	19.68M	18.25M	21.98M	18.18M	16.46M	12.21M	7.77M	7.28M	6.83M	5.10M	4.66M	4.07M
Shareholder's Equity
Total Debt					0.46M	3.72M	1.46M	1.49M	2.95M	2.06M	4.53M	3.51M	4.12M	2.82M	1.70M	500.60M	1.00M	0.80M	0.60M	0.60M
Common Equity	-18.98M	-31.61M	-37.62M	-39.64M	-43.93M	-50.44M	-55.10M	-63.71M	-1.09M	-8.24M	-14.57M	-11.75M	-9.80M	1.97M	7.30M	2.08M	7.20M	3.76M	4.94M	3.13M
Liabilities and Shareholders Equity	232.01M	231.77M	231.24M	231.02M	42.16M	2.60M	43.18M	44.01M	18.59M	10.02M	7.41M	6.43M	6.66M	14.18M	15.06M	9.35M	14.03M	8.86M	9.59M	7.20M
Retained Earnings	-18.98M	-14.69M	-13.24M	-9.24M	-9.90M	-70.36M	-7.88M	-12.15M	-91.34M	-99.57M	-106.80M	-112.60M	-117.62M	-121.72M	-126.70M	-132.42M	-137.60M	-141.62M	-145.73M	-149.90M

Calidi Biotherapeutics Balance Sheet API

Pull Calidi Biotherapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CLDI&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "CLDI", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=CLDI&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

Calidi Biotherapeutics CLDI Balance Sheet (2021-2026)

Calidi Biotherapeutics Quarterly Balance Sheet

Calidi Biotherapeutics Balance Sheet API

Create an account

Sign In

Reset Password